News About: Pharm. Industry
Hanmi Pharm to recruit more 130 jobs in second half
In its globalization vision, Hanmi Pharm plans to hire 130 new and experienced employees by November 6, following its 100 jobs in the first half.
Job seeks will apply for five units export, sales, research & devel...
VGX International to set up plasmid research and production facilities in Chonju
VGX International on October 19 unveiled its plan to establish its research and production facilities for plasmid in an industrial complex in Chonju.
The production facility at Chonju industrial complex is expected...
Glass Lewis ures Dong-A's foreign shareholders to vote against Kang-Korea Alcohol nominees
Dong-A Pharmaceutical Co. announced on October 19 that Glass Lewis & Co, one of the world's leading independent providers of proxy voting recommendations and corporate governance advisory services, have recommended th...
54% of OTC users suffer heart burn
53.7 percent of those who take OTCs, such as digestives, have suffered from heart burn, according to a recently released survey.
The survey of 664 OTC users, conducted by a regional chapter of the Korean Pharmaceut...
Intermittent dosing drives market growth
Although bisphosphonates are the mainstay of osteoporosis treatment, there is potential for new and innovative products to gain market share.
Products that offer intermittent dosing schedules are highly desirable i...
Novo Nordisk is eyeing domestic diabetes market
Novo Nordisk Korea is intensifying heated marketing efforts on a new long-acting insulin analogue Levemir (insulin detemir) to strengthen its presence in local diabetes market.
Levemir is a long-acting basal insul...
KFDA approves Novartis's osteoporosis drug
Novartis Korea said on October 16 that the Korea Food and Drug Administration has approved its osteoporosis medicine Aclasta (zoledronic acid 5 mg) for treatment of women with postmenopausal osteoporosis.
A once-y...
Pharmaceutical firms and pharmacists advised to promote OTCs
Domestic pharmaceutical makers and proprietors of pharmacy should focus on the development of over-the-counter drugs to survive in an era of the Korea-U.S. FTA, Moon Kyun-tae, Vice Chairman of the Korea Pharmaceutical...
Purimed listed in Australian health authority as treatment of depression
Purimed, Korea's biopharmaceutical company, announced on October 17 that its natural product Lotuzol is listed in the Australian Register of Therapeutic Goods (complementary medicine) for the treatment of depression.
...
GCC profits to go to employees
A large proportion of profits in Green Cross Corporation will be offered to all employees in December, largely thanks to the biggest sales of flagship products in September, a senior official said recently.
During...
